All In MedTech

Device Trial Radar · NCT05568069

RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure

Using Cardiovascular Magnetic Resonance Identified Scar as the Benchmark Risk Indication Tool for Implantable Cardioverter Defibrillators in Patients With Non-Ischemic Cardiomyopathy and Severe Systolic Heart Failure

Last checked: Nov 20, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 2,504 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,504

Planned (sponsor's estimate)

Start

Apr 12, 2023

Primary completion

Feb 28, 2029

Study completion Feb 28, 2032

Sponsor

Lead sponsor
University Hospital Southampton NHS Foundation TrustAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
British Heart Foundation; University of Southampton
First posted
Oct 5, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

BRITISH is a UK multicentre trial of patients who have been diagnosed with heart failure due to Non-Ischemic Cardiomyopathy (NICM, or heart failure that is not caused by blocked heart arteries. Participants will be randomised into two groups. Half the participants will receive an Implantable Cardioverter-Defibrillator (ICD) and the other half will not. The aim of the study will be to compare all-cause mortality (death from any cause) between these two groups at 36 months, and longer-term to 10 years. The study has the potential to change international heart failure treatment guidelines and to improve how patients with this condition are managed.

Conditions

  • Heart Failure

Interventions

  • Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronisation Therapy Defibrillator (CRTD)Device

    An ICD is a device that is implanted under the skin under a local anesthetic. It has a battery/generator component and leads which are fixed into the heart chambers. It has the ability to detect dangerous heart rhythms if they occur, and deliver a shock to treat this to help prevent sudden cardiac death. A CRTD is a pacemaker with a defibrillator function.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of patients aliveTime frame: 3 years

Locations

47 sites in 1 country. Site status is shown where the registry gives one.

  • Royal Devon & Exeter Hospital

    Exeter, United Kingdom · Recruiting

  • Morriston Hospital

    Swansea, United Kingdom · Recruiting

  • Wycombe Hospital

    High Wycombe, Buckinghamshire, United Kingdom · Recruiting

44 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.